The Cholinesterase Variant Screen test measures genetic variants that respond abnormally to succinylcholine enzyme activity, affecting medication metabolism, nerve function, and liver health. The test screens for these variants, aiding in tailored treatment approaches and detecting abnormal genotypes effectively in population surveys.